BIRMINGHAM, Ala., May 5, 2022
/PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today
announced that its board of directors has declared a quarterly cash
dividend on its common stock of $0.28
per share, payable on July 20, 2022,
to holders of record on July 13,
2022. These record and payment dates were set for later in
July than usual to accommodate the expected distribution date of
July 1, 2022, for the previously
announced spin off of the Enhabit Home Health and Hospice
business.
About Encompass Health
As a national leader in
integrated healthcare services, Encompass Health (NYSE: EHC) offers
both facility–based and home–based patient care through its network
of inpatient rehabilitation hospitals, home health agencies and
hospice agencies. With a national footprint that includes 147
hospitals, 252 home health locations, and 99 hospice locations in
42 states and Puerto Rico, the
Company provides high–quality, cost-effective integrated
healthcare. Encompass Health is ranked as one of Fortune's 100 Best
Companies to Work For. For more information, visit
encompasshealth.com, or follow us on our newsroom, Twitter,
Instagram and Facebook.
Forward-Looking Statements
Statements contained in this press release which are not
historical facts, such as the timing and effects of the spin off
and rebranding of the home health and hospice business and its
impact on the business model, outlook and guidance, are
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. In addition,
Encompass Health, through its senior management, may from time to
time make forward-looking public statements concerning the matters
described herein. All such estimates, projections, and
forward-looking information speak only as of the date hereof, and
Encompass Health undertakes no duty to publicly update or revise
such forward-looking information, whether as a result of new
information, future events, or otherwise. Such forward-looking
statements are necessarily estimates based upon current information
and involve a number of risks and uncertainties. Actual events or
results may differ materially from those anticipated in these
forward-looking statements as a result of a variety of factors.
While it is impossible to identify all such factors, factors which
could cause actual events or results to differ materially from
those estimated by Encompass Health include, but are not limited
to, the customary conditions to effecting a spin-off transaction,
including the effectiveness of a Form 10 registration statement,
regulatory approvals and receipt of a favorable IRS private letter
ruling, the continued spread of COVID-19, including the
speed, depth, geographic reach and duration of the spread, which
could decrease our patient volumes and revenues and lead to
staffing and supply shortages and associated cost increases;
actions to be taken by Encompass Health in response
to the pandemic; the outcome of the strategic review of the home
health and hospice segment; the legal, regulatory and
administrative developments that occur at the federal, state and
local levels; Encompass Health's infectious disease
prevention and control efforts; Encompass Health's ability
to comply with extensive, complex, and ever-changing regulations in
the healthcare industry; any adverse outcome of various lawsuits,
claims, and legal or regulatory proceedings involving Encompass
Health, including any matters related to yet undiscovered issues,
if any, at acquired companies; potential disruptions, breaches, or
other incidents affecting the proper operation, availability, or
security of Encompass Health's information systems, including
unauthorized access to or theft of patient, business associate, or
other sensitive information; changes, delays in (including in
connection with resolution of Medicare payment reviews or appeals),
or suspension of reimbursement for Encompass Health's services by
governmental or private payors; and other factors which may be
identified from time to time in Encompass Health's SEC filings and
other public announcements, including Encompass Health's
Form 10-K for the year ended Dec. 31,
2021 and Form 10-Q for the quarter ended March 31, 2022.
Media Contact:
Erin
Wendel-Ritter | 205 970-5912
erin.wendel-ritter@encompasshealth.com
Investor Relations Contact:
Mark Miller | 205 970-5860
mark.miller@encompasshealth.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/encompass-health-declares-dividend-on-common-stock-301540857.html
SOURCE Encompass Health Corp.